Marrone Bio Innovations Inc. (NASDAQ:MBII) posted its quarterly earnings results on Monday. The company reported ($0.29) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.22) by $0.07. Marrone Bio Innovations had a negative return on equity of 2,083.14% and a negative net margin of 304.71%.

Marrone Bio Innovations (NASDAQ:MBII) opened at 2.46 on Tuesday. The company has a 50 day moving average price of $1.87 and a 200-day moving average price of $1.22. Marrone Bio Innovations has a 52 week low of $0.60 and a 52 week high of $2.79. The company’s market capitalization is $60.56 million.

Earnings History for Marrone Bio Innovations (NASDAQ:MBII)

Separately, Zacks Investment Research raised Marrone Bio Innovations from a “sell” rating to a “hold” rating in a research note on Wednesday, October 12th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $4.50.

An institutional investor recently bought a new position in Marrone Bio Innovations stock. Ardsley Advisory Partners bought a new position in Marrone Bio Innovations Inc. (NASDAQ:MBII) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 774,438 shares of the company’s stock, valued at approximately $1,324,000. Ardsley Advisory Partners owned approximately 3.15% of Marrone Bio Innovations at the end of the most recent quarter. Institutional investors own 40.60% of the company’s stock.

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

5 Day Chart for NASDAQ:MBII

Receive News & Stock Ratings for Marrone Bio Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations Inc. and related stocks with our FREE daily email newsletter.